Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Aarhus
Ain Shams University
IRCCS San Raffaele
Albert Einstein College of Medicine
Leiden University Medical Center
Shanghai Pulmonary Hospital, Shanghai, China
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Fundación GECP
Medipol University
RenJi Hospital
The First Affiliated Hospital of Guangzhou Medical University
University of Alabama at Birmingham
Instituto Nacional de Cancerologia de Mexico
Boston University
Boston University
Yale University
University Hospital Bispebjerg and Frederiksberg
All India Institute of Medical Sciences, Bhubaneswar
Fundación GECP
Fundación GECP
Fundación GECP
Fundación GECP
Rigshospitalet, Denmark
Fundación GECP